Tech Company Financing Transactions
PACT Pharma Funding Round
Vida Ventures and private investors joined a $75 million Series C venture round for PACT Pharma. The round was announced on 1/14/2020.
Transaction Overview
Company Name
Announced On
1/14/2020
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series C
Investors
Vida Ventures (Lead Investor) (Helen Kim)
Proceeds Purpose
PACT will use the Series C proceeds to expand the scope of its clinical plan to investigate NeoTCR-T cell products targeting multiple neoantigens for a spectrum of solid tumor types.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Corporate Dr.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
PACT Pharma is an independent, privately funded company recently launched by Arcus and scientific founders Jim Heath (Caltech), Toni Ribas (UCLA) and David Baltimore (Caltech). PACT's vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Franzusoff
Chief Financial Officer
Uneek Mehra
Chief Technical Officer
Timothy Moore
Vice President
Stefanie Mandl
Vice President
Susan Whitehead
VP - Finance
Jeroen Grasman
VP - General Counsel
Atulya Agarwal
VP - Human Resources
Maria Simon
VP - Manufacturing
Gregory Yedinak
VP - Regulatory Affairs
Will White
Browse more venture capital transactions:
Prev: 1/14/2020: Tyra Biosciences venture capital transaction
Next: 1/15/2020: Nicoya Lifesciences venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs